Chatham Capital Group, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History
Chatham Capital Group, Inc.
- $566 Million
- Q2 2024
A detailed history of Chatham Capital Group, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Chatham Capital Group, Inc. holds 6,228 shares of XBI stock, worth $607,292. This represents 0.1% of its overall portfolio holdings.
Number of Shares
6,228
Previous 6,308
1.27%
Holding current value
$607,292
Previous $598,000
3.51%
% of portfolio
0.1%
Previous 0.11%
Shares
25 transactions
Others Institutions Holding XBI
# of Institutions
922Shares Held
99.9MCall Options Held
24.7MPut Options Held
43.4M-
Goldman Sachs Group Inc New York, NY9.88MShares$964 Million0.17% of portfolio
-
Citigroup Inc8.82MShares$860 Million0.56% of portfolio
-
Jpmorgan Chase & CO New York, NY7.85MShares$765 Million0.07% of portfolio
-
Bank Of America Corp Charlotte, NC7.64MShares$745 Million0.07% of portfolio
-
Morgan Stanley New York, NY7.3MShares$712 Million0.06% of portfolio